Dr. Shirley W. Pang, MD

Dr. Pang practices at Providence Medical Foundation in Fullerton, California.

Dr. Pang's NPI, 1457437626, was assigned on October 31, 2006. Dr. Pang graduated from David Geffen School of Medicine at UCLA in 2001. Dr. Pang holds California license A80798.

Dr. Pang's primary practice is Providence Medical Foundation, at 2141 N Harbor Blvd, Fullerton, CA 92835 in Orange County. The practice phone is (714) 449-4900.

Dr. Pang's primary practice is Providence Medical Foundation in Fullerton, California. Dr. Pang is also affiliated with Providence St. Jude Medical Center. The medical group on file is St. Jude Heritage Medical Group. Dmand AI also links Dr. Pang to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pang practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Pang's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Pang is board certified in rheumatology by the American Board of Internal Medicine. Dr. Pang is licensed in California.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint arthropathy, joint pain and lupus among the conditions Dr. Pang treats.

CMS data shows 1,200 Medicare services from Dr. Pang across 7 procedure codes in 2024, for 482 Medicare patients. Medicare paid $70,797 for them. Every service was in an office.

CMS counts 482 Medicare patients who saw Dr. Pang in 2024. The largest group is 65 to 74, with 243 patients. 75% of them have arthritis, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pang's median patient age at 70, with 84% women.

In 2024, Dr. Pang wrote 2,194 Medicare Part D claims for 460 patients. 85% of them were for generic drugs. CMS names the drug for 1,979 of them, across 34 drugs with 11 or more claims each, at $1,341,709 in total drug cost. In 2023, CMS named 2,016 claims across 35 drugs.

Dr. Pang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pang as offering telehealth.

Dmand AI links 3 papers to Dr. Pang, published from 2018 to 2021. The most frequent topics are Disease Progression, Double-Blind Method and Pain Measurement. Dr. Pang's most frequent co-authors are Shaili Deveshwar, MD, Richard W. Easton, MD and Anton Khlopas, MD.

Dmand AI links Dr. Pang to 11 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Arthritis, Rheumatoid, Rheumatic Diseases and Diabetes Mellitus, Type 2. Eli Lilly and Company sponsors the most, 8. Open Payments lists research payments to Dr. Pang that name 7 trials.

CMS Open Payments shows 1,829 general payments to Dr. Pang from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Celgene Corporation paid the most, $91,234. It also lists 15 research payments totaling $8,415 from 2016 to 2025, naming 7 clinical trials.

Dmand AI lists 1 award for Dr. Pang, most recently CMS Stage 1 EHR in 2012.

Dr. Pang graduated from David Geffen School of Medicine at UCLA in 2001.

Dr. Pang is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.